Shopping Cart
Remove All
Your shopping cart is currently empty
Talacotuzumab-MMAE, an antibody-drug conjugate (ADC), combines an IL-3Rα-targeting antibody with Monomethyl auristatin E (MMAE) and is utilized in acute myeloid leukemia research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | Talacotuzumab-MMAE, an antibody-drug conjugate (ADC), combines an IL-3Rα-targeting antibody with Monomethyl auristatin E (MMAE) and is utilized in acute myeloid leukemia research. |
| Synonyms | Anti-IL-3Ra / CD123 Reference Antibody |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Molecular Weight | 145 kDa |
| Storage | -20°C for 1 year | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.